Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.

B Hu1, J Ellingboe, S Han

  • 1Chemical Sciences and Cardiovascular/Metabolic Diseases Research, Wyeth-Ayerst Research, Pearl River, New York 10965, USA. hub@war.wyeth.com

Journal of Medicinal Chemistry
|April 20, 2001
PubMed
Summary

Researchers developed novel (4-piperidin-1-yl)phenyl amides as potential treatments for obesity and type II diabetes. Compounds 26e and 33b demonstrated high potency and selectivity as human beta(3) adrenergic receptor agonists.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.

Journal of endocrinological investigation·2022
Same author

[Analysis of clinical features and poor prognostic factors of acute hematogenous osteomyelitis in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2022
Same author

Gastrointestinal: Endoscopic submucosal tunnel dissection for an esophageal bronchogenic cyst.

Journal of gastroenterology and hepatology·2022
Same author

Re: A prospective study of multimodal cocktail intercostal injection for chest pain relief after costal cartilage harvest for rhinoplasty. Assessing analgesic efficacy of multimodal cocktail injection after costal cartilage harvest for rhinoplasty.

The British journal of oral & maxillofacial surgery·2022
Same author

Assessing prevalence and independent predictors of postoperative delirium in patients with head and neck cancer.

The British journal of oral & maxillofacial surgery·2022
Same author

Retraction Note: OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

Cell death & disease·2022

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Endocrinology

Background:

  • Obesity and type II diabetes are significant global health concerns.
  • Human beta(3)-adrenergic receptor agonists are being investigated for therapeutic potential in these conditions.
  • Development of selective agonists is crucial to minimize side effects.

Purpose of the Study:

  • To synthesize and evaluate a series of (4-piperidin-1-yl)phenyl amides.
  • To identify potent and selective human beta(3)-adrenergic receptor agonists.
  • To assess the therapeutic potential for obesity and type II diabetes.

Main Methods:

  • Chemical synthesis of (4-piperidin-1-yl)phenyl amide derivatives.
  • In vitro biological activity evaluation on human beta(3)-adrenergic receptor.

Related Experiment Videos

  • Assessment of receptor selectivity against beta(1) and beta(2) receptors.
  • In vivo thermogenesis studies using human beta(3)-adrenergic receptor transgenic mice.
  • Main Results:

    • Compounds 26e and 33b emerged as the most potent and selective agonists.
    • EC(50) values for 26e and 33b at the beta(3) receptor were 0.008 and 0.009 microM, respectively.
    • Compounds exhibited negligible activity at beta(1) and beta(2) receptors.
    • Significant thermogenesis effects were observed in transgenic mice.

    Conclusions:

    • The synthesized (4-piperidin-1-yl)phenyl amides, particularly 26e and 33b, represent highly potent and selective human beta(3) agonists.
    • These compounds hold promise as potential drug candidates for treating human obesity and type II diabetes.
    • Further research is warranted to explore their full therapeutic potential.